Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Effects of Sildenafil in BPH Patients on Doxazosin
NCT00645034Phase 2Completed
- Sponsor
- Viatris
- Start
- Nov 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ASP-001 in benign prostatic hyperplasia (BPH), sponsored by Viatris. Started Nov 2002; status: completed.
02
Drugs
ASP-001
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00645034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00645034.